Short Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Decreases By 40.1%
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) saw a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 478,300 shares, a decline of 40.1% from the February 13th total of 797,900 shares. Currently, 1.3% of the company’s shares are short sold. Based on an […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) saw a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 478,300 shares, a decline of 40.1% from the February 13th total of 797,900 shares. Currently, 1.3% of the company’s shares are short sold. Based on an […]
